New Duodenoscope Cleaning Instructions Issued for Reprocessing Procedure

New Duodenoscope Cleaning Instructions Issued for Reprocessing Procedure

The Food and Drug Administration (FDA) has announced that new, validated manual reprocessing instructions have been issued by Olympus for the TJF-Q180V endoscopic retrograde cholangiopancreatography (ERCP) endoscopes (duodenoscopes) after reports of multi-drug resistant bacterial infections in patients in patients who have undergone ERCP with reprocessed duodenoscopes, even when the manufacturer reprocessing instructions are correctly followed.

Educating Clinicians on Safe Opioid Prescribing Part of New HHS Program

Educating Clinicians on Safe Opioid Prescribing Part of New HHS Program

The U.S. Department of Health and Human Services (HHS) has announced a targeted initiative, including educational initiatives for healthcare professionals, to reduce prescription opioid and heroin related overdose, death, and dependence.

Targeted Immunotherapy for Alzheimer's Could Reverse Memory Problems

Targeted Immunotherapy for Alzheimer's Could Reverse Memory Problems

Memory problems associated with Alzheimer's disease may one day be reversed with targeted immunotherapy, according to a new study appearing in the Journal of Neuroscience.

NIH: HIV Can Evolve, Replicate in Brain During Early Infection

NIH: HIV Can Evolve, Replicate in Brain During Early Infection

Researchers have found that the HIV virus can evolve and independently replicate in patients' brains early in the process.

Comparing Roseroot Herb, Sertraline for MDD Treatment

Comparing Roseroot Herb, Sertraline for MDD Treatment

The roseroot herb (Rhodiola rosea) may be a beneficial treatment option for major depressive disorder (MDD), a study published in Phytomedicine has shown.

Harmless Bacteria May Help Prevent Meningococcal Spread

Harmless Bacteria May Help Prevent Meningococcal Spread

A study published in Clinical Infectious Diseases suggests a new way to prevent outbreaks of meningococcal disease through nasal inoculation of the harmless Neisseria lactamica.

Why a Clean House May Not Lower Asthma, Allergy Risk

Why a Clean House May Not Lower Asthma, Allergy Risk

Despite the widely accepted assumption that the rise in allergic disorders may be due to improved hygiene, a new study has found no connection between development of allergies and asthma and personal hygiene or home cleanliness.

Study: Pregnant, Breastfeeding Women Not Consuming Enough of This Nutrient

Study: Pregnant, Breastfeeding Women Not Consuming Enough of This Nutrient

Results from a large birth cohort study suggest women may not be consuming enough omega-3 to meet the recommendations for pregnancy and lactation.

First-in-Class Test to Aid IVF Embryo Selection Approved

First-in-Class Test to Aid IVF Embryo Selection Approved

Auxogyn announced the availability of the Eeva Test to help the embryo selection process by taking images of the embryos during the incubation period.

New Genetic Variant Linked to Severe Autism Identified

New Genetic Variant Linked to Severe Autism Identified

A newly discovered rare genetic variant linked to autism spectrum disorder (ASD) could shed light on the role of synaptic function and cognitive defects associated with the disorder.

Orphan Drug Status Granted to Mesothelioma Therapy

Aduro Biotech announced that the Food and Drug Administration (FDA) has granted Orphan Drug designation to CRS-207 for the treatment of mesothelioma.

Xylitol Effects in Cavity Prevention Reviewed

Xylitol Effects in Cavity Prevention Reviewed

There is little high quality evidence proving the effect of xylitol in preventing dental cavities, new research published in the Cochrane Library has found.

Hunger, Weight Gain Risk With These Diabetes Drugs - But Why?

Hunger, Weight Gain Risk With These Diabetes Drugs - But Why?

A specific drug class for the treatment of type 2 diabetes has been linked to an increased risk of weight gain, and researchers have new clues as to how these medications may activate sensors in the brain that lead to increased hunger.

Quadracel Vaccine Approved for Peds DTaP Series

Sanofi Pasteur announced that the Food and Drug Administration (FDA) has approved Quadracel (diphtheria and tetanus toxoids and acellular pertussis absorbed and inactivated poliovirus [DTaP-IPV]) vaccine for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in children ages 4 to 6 years.

Eylea Now Approved for Diabetic Retinopathy in DME

Eylea Now Approved for Diabetic Retinopathy in DME

The Food and Drug Administration (FDA) has granted expanded the use of Eylea (aflibercept; Regeneron) injection to treat diabetic retinopathy in patients with diabetic macular edema (DME).

Anthrasil Approved for Inhalation Anthrax

Anthrasil Approved for Inhalation Anthrax

Emergent BioSolutions announced that the Food and Drug Administration (FDA) has approved Anthrasil (anthrax immune globulin intravenous [human]), also known as AIGIV, for the treatment of inhalation anthrax in combination with appropriate antibacterial drugs.

Oxaydo for Pain Management Coming Soon

Oxaydo for Pain Management Coming Soon

Egalet announced plans to launch Oxaydo (oxycodone HCl) tablets for the management of acute and chronic moderate to severe pain where the use of an opioid analgesic is appropriate.

Changes to Pancreatic Cyst Management in New AGA Guideline

Changes to Pancreatic Cyst Management in New AGA Guideline

The American Gastroenterological Association (AGA) has released a new guideline for physicians in the appropriate monitoring of patients with pancreatic cysts.

Study: Mothers Report More GI Symptoms in Children With Autism

Study: Mothers Report More GI Symptoms in Children With Autism

A new study has found that maternally reported gastrointestinal (GI) symptoms in children are more common in children with autism spectrum disorder (ASD) in the first three years of life compared to children with typical development or developmental delay (DD).

Ebola Vaccine Based on Current Strain Provokes Immune Response in First Phase 1 Trial

Ebola Vaccine Based on Current Strain Provokes Immune Response in First Phase 1 Trial

Researchers have published results from the first Phase 1 trial of an Ebola vaccine developed based on the 2014 Zaire Guinea Ebola strain in The Lancet.

Non-Alcohol Formula of Docetaxel Injection Submitted for FDA Review

Teikoku Pharma USA announced that it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for Docetaxel Injection Concentrate, Non-Alcohol Formula for the treatment of breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric adenocarcinoma, and head and neck cancer.

FDA Approves Epivir, Ziagen Labeling Updates

The Food and Drug Administration (FDA) has approved labeling revisions for Epivir (lamivudine; GlaxoSmithKline) and Ziagen (abacavir sulfate; GlaxoSmithKline) to include a pediatric dosing update.

No More Latex-Free Claims, Recommends FDA

No More Latex-Free Claims, Recommends FDA

The Food and Drug Administration (FDA) is recommending that manufacturers stop using the labels "latex-free" or "does not contain latex" due to the scientific inaccuracy of these claims.

TB Discovered 133 Years Ago Today, Yet Still One of the World's Deadliest Diseases

TB Discovered 133 Years Ago Today, Yet Still One of the World's Deadliest Diseases

The National Institutes of Health (NIH) has issued a statement for World TB Day on the need to effectively diagnose, treat, and cure those infected with tuberculosis (TB).

Look-a-Like Injectables Prompt ASHP, ISMP to Issue National Alert

The ASHP and ISMP have issued a National Alert for Serious Medications Errors regarding potentially dangerous mix-ups of neostigmine injection and phenylephrine injection.

Parents Who Smoke May Increase Child's Heart Disease Risk

Parents Who Smoke May Increase Child's Heart Disease Risk

A new study reported that children exposed to their parents' smoking may have a higher risk of developing heart disease in adulthood than those whose parents didn't smoke.

Study Explores Why COPD Drug May Lose Efficacy Over Time

Roflumilast may become less effective in treating chronic obstructive pulmonary disease (COPD) over time due to an increased production of a protein that causes inflammation, which may result in the patient possibly developing tolerance.

Vitamin D3 + Metformin May Lower Colon Cancer Risk More Than Either Alone

Vitamin D3 + Metformin May Lower Colon Cancer Risk More Than Either Alone

Vitamin D3 and metformin have individually shown promise in reducing the risk of colorectal cancer, but a new study in the journal Cancer Prevention Research indicates that combined use may be significantly more effective than either vitamin D or metformin alone.

More Milk May Protect Brain Function, Study Finds

More Milk May Protect Brain Function, Study Finds

Researchers from the University of Kansas Medical Center have found that drinking milk may be linked to levels of glutathione in the brains of healthy older adults.

Why Aren't Physicians Disclosing Alzheimer's Dx to Patients, Caregivers?

Why Aren't Physicians Disclosing Alzheimer's Dx to Patients, Caregivers?

In a new report from the Alzheimer's Association, only 45 percent of patients with Alzheimer's disease or their caregivers stated that they were told the diagnosis by their physician and were more likely to be told the diagnosis after the disease had become more advanced.

FDA Approves Mini Blood Pump System

The Food and Drug Administration (FDA) has approved Abiomed's Impella 2.5 System, a mini blood pump system intended for temporary use by patients with severe symptomatic coronary artery disease (CAD) and diminished but stable heart function who are undergoing high-risk percutaneous coronary intervention (HRPCI) procedures.

Keytruda Results May Halt Melanoma Trial Early

Merck announced results from the Phase 3 KEYNOTE-006 study investigating Keytruda (pembrolizumab) vs. ipilimumab in the first-line treatment of patients with advanced melanoma.

FDA Finishes Review of Patient Deaths Post-Zyprexa Relprevv Injection

The FDA stated the study results were inconclusive regarding the investigation of two deaths following the injection of Zyprexa Relprevv (olanzapine pamoate; Eli Lilly) from June 2013.

Zinc Deficiency Linked to Increased Inflammation, Especially in Elderly

Zinc deficiency may be linked to chronic diseases that involve inflammation, new research has shown.

Study: Abuse, Addiction, Poisoning Diagnoses Decrease with Reformulated Oxycontin

Study: Abuse, Addiction, Poisoning Diagnoses Decrease with Reformulated Oxycontin

New data presented at the American Academy of Pain Medicine's 31st Annual Meeting shows a reduction in abuse, addiction, and opioid poisoning diagnoses following the introduction of reformulated Oxycontin (oxycodone HCl extended-release tablets; Purdue Pharma).

Artificial Sweetener May Play Role in New Cancer Tx Development

Artificial Sweetener May Play Role in New Cancer Tx Development

The main ingredient found in Sweet 'N Low, Sweet Twin, and Necta may potentially lead to the development of oncology drugs to treat aggressive cancers.

Study: 1 in 10 Patients Do This to Their Pills

Study: 1 in 10 Patients Do This to Their Pills

One in ten people reported modifying their medication dosage forms, resulting in potentially reduced efficacy, a study has found.

New Titration Dose for Vyvanse Available

New Titration Dose for Vyvanse Available

Shire announced that Vyvanse (lisdexamfetamine dimesylate) is now available in a new 10mg dosage strength.

First Response Women's Multivitamin Line Coming Soon

First Response Women's Multivitamin Line Coming Soon

Church & Dwight announced the expected launch of First Response Reproductive Health Multivitamin Gummies and PreNatal & PostNatal Multivitamin Gummies, an extension of the First Response product line.

Glyxambi Available for Type 2 Diabetes

Glyxambi Available for Type 2 Diabetes

Glyxambi (empagliflozin/linagliptin; Boehringer Ingelheim and Eli Lilly) tablets are now available as adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes when both empagliflozin and linagliptin are appropriate treatments.

FDA Lifts Clinical Hold, Tanezumab Trial to be Resumed

Pfizer and Eli Lilly and Company announced that they are preparing to resume the Phase 3 clinical pain program for tanezumab.

FDA: Life-Threatening Interaction Possible Between Antivirals, Amiodarone

FDA: Life-Threatening Interaction Possible Between Antivirals, Amiodarone

The FDA has issued a new safety warning regarding cases of serious and life-threatening symptomatic bradycardia as well as one case of fatal cardiac arrest following the co-administration of amiodarone with either Harvoni (ledipasvir and sofosbuvir fixed-dose combination; Gilead Sciences) or with Sovaldi (sofosbuvir; Gilead Sciences) in combination with another direct-acting antiviral (DAA).

Which Interventions Had Strongest Impact on Obesity-Related Outcomes?

Which Interventions Had Strongest Impact on Obesity-Related Outcomes?

Certain interventions were more successful than others in improving obesity-related outcomes, according to a recent review published in Obesity Reviews.

New Data Shows Tofacitinib Effective for Plaque Psoriasis

Pfizer announced results from two Phase 3 studies from the Oral treatment Psoriasis Trials (OPT) program for tofacitinib citrate in adults with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.

Long-Term Efficacy Data for Otezla in Plaque Psoriasis Announced

Celgene announced results from the ESTEEM Phase 3 clinical program for Otezla (apremilast) in patients with moderate to severe plaque psoriasis.

Acne Medication Rxs Often Go Unfilled, Says New Survey

Over 25% of patients with acne did not obtain medications prescribed by their dermatologists, according to a survey by Wake Forest Baptist Medical Center researchers.

Combo Acne Drug Reduces Lesion Count in Trial

Galderma announced positive Phase 3 results for adapalene 0.3%/benzoyl peroxide 2.5% (0.3% A/BPO) topical gel.

Genetically Engineered Apples, Potatoes OK'd by the FDA

Genetically Engineered Apples, Potatoes OK'd by the FDA

After completing its evaluation, the U.S. Food and Drug Administration (FDA) concluded that two varieties of apples and six varieties of potatoes, all of which were genetically engineered, are as safe and nutritious as their conventional counterparts.

Short-Course Doxycycline May Be OK for Younger Children

Researchers from the Centers for Disease Control and Prevention (CDC) and Indian Health Service (IHS) have found that short treatment courses of doxycycline can be administered in children <8 years old without staining teeth or weakening tooth enamel.

New Research: Impact of Hydrocodone Combination Product Rescheduling on Pain Patients

New Research: Impact of Hydrocodone Combination Product Rescheduling on Pain Patients

Based on preliminary analysis of a new survey, chronic pain patients are finding it harder to access hydrocodone combination products (HCP) after the Drug Enforcement Administration (DEA) rescheduling, resulting in greater expenses for patients and strained doctor-patient relationships.

Two Older Antibiotics Effective Against Community-Acquired MRSA, Says New Research

Two Older Antibiotics Effective Against Community-Acquired MRSA, Says New Research

Two common antibiotics have been shown to be equally effective in treating uncomplicated community-acquired skin infections like methicillin-resistant Staphylococcus aureus (MRSA), according to a new study in the New England Journal of Medicine.

Over 50,000 Bottles of Cholesterol Drug Recalled

Micro Labs announced a voluntary recall of 54,096 bottles of Simvastatin Tablets due to failed impurities/degradation specifications.

Don't Rely on OTC Homeopathic Asthma Products, Warns FDA

Don't Rely on OTC Homeopathic Asthma Products, Warns FDA

The Food and Drug Administration (FDA) is warning consumers to not rely on over-the-counter (OTC) asthma products labeled as homeopathic.

Rapid Blood Test Could Help Differentiate Bacterial vs. Viral Infection

Rapid Blood Test Could Help Differentiate Bacterial vs. Viral Infection

An in vitro rapid blood assay has been shown to differentiate between bacterial and viral infections with significant sensitivity and specificity, outperforming routine biomarker and laboratory tests.

New Hybrid Diet Found to Cut Alzheimer's Risk, Even Without Strict Adherence

New Hybrid Diet Found to Cut Alzheimer's Risk, Even Without Strict Adherence

The MIND diet may significantly reduce the risk of developing Alzheimer's disease even if the diet is not rigorously followed, an article has shown.

New Prescription Vitamin B12 Tabs May Eliminate Need for Injection

New Prescription Vitamin B12 Tabs May Eliminate Need for Injection

Emisphere Technologies announced the launch of Eligen B12 (cyanocobalamin 100mcg, salcaprozate sodium [SNAC] 100mg) for the dietary management of patients who have a vitamin B12 deficiency associated with a disease or condition that cannot be managed by a modification of the normal diet alone.

Cholesterol-Lowering Effects of Atorvastatin May Be Greater in Some More Than Others

Cholesterol-Lowering Effects of Atorvastatin May Be Greater in Some More Than Others

An updated review on the effects of varying doses of atorvastatin on serum total cholesterol, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)- cholesterol, and triglycerides in patients with and without evidence of cardiovascular disease confirms previous evidence of the drug's dose-related effects on blood lipids.

The Impact of Antipsychotics on Mortality Risk in Seniors with Dementia

The Impact of Antipsychotics on Mortality Risk in Seniors with Dementia

Older patients with dementia taking certain antipsychotic medications may have a greater mortality risk compared to those taking an anticonvulsant and certain antidepressants, according to a new study appearing in JAMA Psychiatry.

Adding BP Drug May Lessen Topical Steroid Side Effects

An antihypertensive was found to reduce side effects from corticosteroid-based creams used for certain skin diseases, reports a study published in the Journal of Investigative Dermatology.

Study: Current Healthcare Models Ineffective for Chronic Disease Management

An article published in The American Journal of Medicine has identified four factors that may negatively impact the delivery of chronic disease care in the U.S. and proposed changes to the model for improving treatment to the estimated 48 percent of the total population that will suffer from chronic disease by 2020.

Gut Bacteria, ASD, and Probiotics: Exploring the Relationship

Gut Bacteria, ASD, and Probiotics: Exploring the Relationship

New evidence has emerged exploring the relationship between gut microbiome, autism spectrum disorder (ASD), and probiotic treatment.

Illicit Fentanyl Use on the Rise, DEA Warns

Illicit Fentanyl Use on the Rise, DEA Warns

The DEA has issued a nationwide warning on the dangers of illicit fentanyl and its analogues/compounds being laced in heroin, which can lead to significant problems especially with rising heroin abuse.

New Indoor Use Eyewear for Color Blind Deficiency Coming Soon

New Indoor Use Eyewear for Color Blind Deficiency Coming Soon

EnChroma announced a new line of EnChroma Cx-65 eyewear for indoor use that enables people with color vision deficiency (CVD) to see colors indoors.

Expanded Age Range for Kalydeco Now Approved

Expanded Age Range for Kalydeco Now Approved

Vertex Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved Kalydeco (ivacaftor) for use in children ages 2-5 with cystic fibrosis (CF) who have one of 10 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Orphan Status Granted to Investigational Pulmonary Arterial Hypertension Drug

The Food and Drug Administration (FDA) has granted Orphan Drug designation to tacrolimus (SPI-026; Selten Pharma) for the treatment of pulmonary arterial hypertension.

First Drug Approved for Rare Bile Acid Synthesis Disorders

The Food and Drug Administration (FDA) has approved Cholbam (cholic acid; Asklepion) capsules for the treatment of patients three weeks and older with bile acid synthesis disorders due to single enzyme defects, and as adjunct to standard of care for patients with peroxisomal disorders (including Zellweger spectrum disorders).

Genetics Could Play Role With Aspirin, NSAIDs, and CRC Risk

Genetics Could Play Role With Aspirin, NSAIDs, and CRC Risk

Researchers from Indiana University have identified genetic markers to hep determine which patients benefit from regular aspirin and other NSAIDs for reducing the risk of developing colorectal cancer.

OTC Cough Remedy May Prove Beneficial in Type 2 Diabetes

OTC Cough Remedy May Prove Beneficial in Type 2 Diabetes

In a recent study published in Nature Medicine, an active ingredient in many over-the-counter cough remedies improved blood glucose levels in type 2 diabetes and could also be beneficial for type 1 diabetes.

CV Protection With HRT + Statins May Depend on Estrogen Type

CV Protection With HRT + Statins May Depend on Estrogen Type

Hormone therapy combined with statins may help protect women from heart disease or stroke after menopause, data from a Swedish population study has shown.

Bivalirudin Beats Heparin for PCI Patients in BRIGHT Study

Bivalirudin was superior to both heparin plus tirofiban and heparin alone in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI), a multi-center trial has found.

Diabetes Drug Classes That Increase HF Risk ID'ed

Diabetes Drug Classes That Increase HF Risk ID'ed

Some glucose-lowering medications may increase the risk of heart failure in patients with or at risk for type 2 diabetes, with variations seen among different drug classes.

Four Factors Can Improve Drug Adherence in Diabetic Seniors

Four Factors Can Improve Drug Adherence in Diabetic Seniors

Prescriptions for more than a 90 day supply, mail-order pharmacy use, and lower copayments and out-of-pocket maximums nearly doubled the chances that older patients adhered to their prescribed heart and diabetes medications, a new study has shown.

Smart Bandage Could Prevent Bed Sores With Early Detection

Smart Bandage Could Prevent Bed Sores With Early Detection

A new "smart bandage" has been developed that can detect early tissue damage from pressure ulcers before they are visible to the human eye.

New Drug Molecule May Prevent MS Disease Progression

Scientists from the Walter and Eliza Hall Institute have developed a molecule that inhibits a key inflammation trigger and prevents the progression of multiple sclerosis (MS).

Longer Antiplatelet Tx After Drug-Eluting Stent May Not Benefit All Patients

Extended duration antiplatelet therapy (DAPT) after drug-eluting stent implantation was linked to higher rates of mortality compared to shorter DAPT, a meta-analysis has shown.

Imbruvica Significantly Delays Disease Progression in CLL/SLL Study

Results have been announced from a pre-planned interim analysis of the Phase 3 HELIOS (CLL3001) trial studying the combination of Imbruvica (ibrutinib; Pharmacyclics and Janssen Biotech) plus bendamustine and rituximab (BR) vs. placebo plus BR in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

Sticking to Mediterranean Diet May Lower Dementia, Alzheimer's Risk

Sticking to Mediterranean Diet May Lower Dementia, Alzheimer's Risk

Improved adherence to the Mediterranean diet may reduce the incidence of cognitive decline, dementia, and Alzheimer's disease, a new analysis published in Advances in Nutrition suggest.

Study Says Obese Patients May Be Deficient in This Vitamin

Thiamin (vitamin B1) deficiency was found in up to one-third of obese patients seeking bariatric surgery, according to data from a large-scale study.

Diet Soda May Actually Increase Waistline in Older Adults

Diet Soda May Actually Increase Waistline in Older Adults

An increase in diet soda consumption is directly linked to greater visceral adiposity in older adults, reports a new study in the Journal of the American Geriatrics Society.

Study: More CV Events Reduced With Vytorin vs. Statin Alone

Merck announced results from a pre-specified exploratory analysis of an investigational study on ezetimibe/simvastatin (Vytorin) and total cardiovascular events compared to simvastatin alone.

New Viibryd Strength Expands Dosing Options for MDD

Actavis announced that the Food and Drug Administration (FDA) has approved Viibryd (vilazodone HCl) tablets in a new 20mg dosage strength.

Gadolinium Deposits Found in Brain Tissue After IV Contrast Agent Use

Evidence of gadolinium deposits in neuronal tissues following intravenous (IV) gadolinium-based contrast agents have been found, researchers from the Mayo Clinic reported.

Catheter Ablation or Amiodarone: Which Has Better Outcomes in A-Fib, HF?

New research suggests that patients with heart failure and atrial fibrillation may have improved outcomes with catheter ablation compared to treatment with amiodarone.

Bigger Breakfast Better for Glucose Control?

Bigger Breakfast Better for Glucose Control?

A new study suggests consuming a high-caloric breakfast and a more modest dinner may suppress blood glucose spikes throughout the day.

Antiarrhythmic Drug Now Available in Oral Solution Formulation

Antiarrhythmic Drug Now Available in Oral Solution Formulation

Arbor announced the launch of Sotylize (sotalol HCl) oral solution for the treatment of life-threatening ventricular arrhythmias and for the maintenance of normal sinus rhythm in patients with highly symptomatic atrial fibrillation/atrial flutter

Psoriasis Symptoms Improve After Single Dose of Experimental Antibody Tx in Study

Patients with moderate-to-severe psoriasis showed significant recovery after a single dose of an experimental human antibody treatment that targets interleukin-23, a study showed.

Smoking Cessation Guidelines for Cancer Patients Released

Smoking Cessation Guidelines for Cancer Patients Released

The National Comprehensive Cancer Network (NCCN) has released Clinical Practice Guidelines in Oncology for Smoking Cessation.

How Much Zinc Is Needed to Cut Cold Duration, Symptoms?

How Much Zinc Is Needed to Cut Cold Duration, Symptoms?

While trials on the efficacy of zinc lozenges for cold symptoms have led to mixed results, a new meta-analysis has found that high-dose zinc acetate lozenges may reduce the duration of some cold symptoms by nearly 50 percent.

Adding Folic Acid May Help Reduce Stroke Risk in Some, Study Finds

Adding Folic Acid May Help Reduce Stroke Risk in Some, Study Finds

The combined use of enalapril and folic acid significantly reduced the risk of first stroke compared with enalapril alone, a study published in the JAMA has shown.

Novel Anti-Clotting Therapy Trial Permanently Halted Due to AEs

Regado BioSciences announced the permanent hold of the Phase 3 REGULATE-PCI trial in August 2014, which compared Revolixys Kit (pegnivacogin/anivamersen; REG1 Anticoagulation System) to bivalirudin in patients undergoing percutaneous coronary intervention (PCI).

First-of-Kind Implant to Reduce Stroke in High-Risk Patients Approved

First-of-Kind Implant to Reduce Stroke in High-Risk Patients Approved

Boston Scientific announced that the Food and Drug Administration (FDA) has approved WATCHMAN Left Atrial Appendage Closure Device to reduce the risk of stroke in high-risk patients with non-valvular atrial fibrillation who are looking for an alternative to long-term warfarin therapy.

New Data on Novel Investigational Cholesterol Drug, CV Events

New Data on Novel Investigational Cholesterol Drug, CV Events

Amgen announced one-year results from prespecified exploratory endpoints of adjudicated cardiovascular events in the Phase 2 (OSLER-1) and Phase 3 (OSLER-2) open-label extension studies of Repatha (evolocumab) for the treatment of high cholesterol.

Long-Term Study on Brilinta Safety, Efficacy Announced

Long-Term Study on Brilinta Safety, Efficacy Announced

AstraZeneca announced results from the PEGASUS-TIMI 54 study that evaluated Brilinta (ticagrelor) tablets with low-dose aspirin vs. placebo for the chronic secondary prevention of atherothrombotic events in patients with a history of heart attack one to four years prior to study enrollment.

First Nasal Gel for Testosterone Replacement Tx Launched

First Nasal Gel for Testosterone Replacement Tx Launched

Endo announced the launch of Natesto (testosterone nasal gel), the first nasal gel for testosterone replacement therapy in adults with hypogonadism.

Quadrivalent vs. Trivalent Flu Vaccines: Comparing Responses to B Strains

Quadrivalent vs. Trivalent Flu Vaccines: Comparing Responses to B Strains

Research in the journal Vaccine indicates that an intradermal quadrivalent influenza vaccine offers greater antibody response to the B lineage strains compared to a trivalent vaccine.

BP Screening in Non-Primary Care Settings Can ID More Patients

BP Screening in Non-Primary Care Settings Can ID More Patients

Expanding screening for hypertension to non-primary care settings could improve detection of hypertension and contribute to improved blood pressure management, according to research appearing in The Journal of Clinical Hypertension.

Energy Drinks: Potential BP Danger for Caffeine-Naive Adults

Energy Drinks: Potential BP Danger for Caffeine-Naive Adults

Young adults who don't regularly consume caffeine had a higher increase in resting blood pressure after drinking a commercially available energy drink vs. a placebo drink, researchers from the Mayo Clinic found.

Herpes Drug Reduces HIV Levels Even in Those Without Herpes

Herpes Drug Reduces HIV Levels Even in Those Without Herpes

Valacyclovir may reduce levels of HIV in patients without genital herpes, a National Institutes of Health (NIH) study has found.

BAX 817 for Hemophilia A/B: New Results from Phase 3 Trial

BAX 817 for Hemophilia A/B: New Results from Phase 3 Trial

Baxter announced positive results from a Phase 3 trial evaluating BAX 817 for the treatment of patients with hemophilia A or B who develop inhibitors.

Clinical MS Symptoms Alleviated by Hypertension Tx in Study

A hypertension medication may prevent myelin loss and alleviate clinical symptoms of multiple sclerosis (MS) based on a study in animal models, according to newly published research in the journal Nature Communications.

Sign Up for Free e-newsletters